Breakthrough science, expert insights, and can’t-miss sessions await!
Our 2026 scientific program features over 200 sessions designed to expand your professional knowledge and highlight the latest breakthroughs in diabetes care. Explore symposia, late-breaking clinical trials, panel discussions, and more, including:
- GLP-1 Receptor Agonists: What's New in 2026?
- REIMAGINE 1, 2, 3: Leveraging Amylin and GLP-1 for Type 2 Diabetes Care with CagriSema
- Dual Agonism in Type 1 Diabetes: Unveiling Efficacy and Safety of Adjunct Therapy with CT-868 (GLP-1/GIP RA) in Adults with Type 1 Diabetes—Phase 1 and 2 Results
- From Pen to Pill: Achieving a Paradigm Shift in Type 2 Diabetes—The Orforglipron "ACHIEVE" Clinical Trial Program
- AI and Innovation for Clinical Health Care Delivery in DM
- Where Heart, Kidney, and Metabolism Collide: Innovations in the Holistic Approach to Care
- The New Frontier of Hypoglycemia Prevention: Pathophysiology, Therapies, Technology, and Care
- And much more!
Not Registered?
Register for on-demand access to the groundbreaking science presented at the meeting.
Mark Your Calendar
